K-pop

Cat's Eye's "Animal" Ranks No. 18 on the UK Official Singles Chart… Remains in the Top Ranks for the Second Week

Collaboration Track Enters the Charts… Gaining Traction in the UK Kedehun OST “Golden” Ranks 49th… Remains on the Charts for 59 Weeks

YUN GI BACK
2026-08-08 11:27:52
[Edaily Starin YUN GI BACK Reporter] The group KATSEYE continued its global success by maintaining a top position on the UK Official Singles Chart with their new song “ANIMAL.”
KATSEYE (Photo: HYBE·Geffen Records)

According to the UK Official Charts released on the 7th (local time), KATSEYE’s “ANIMAL” ranked 18th on the Official Singles Top 100. Although it dropped two spots from the previous week, it remained in the upper ranks of the chart for two consecutive weeks, demonstrating its steady popularity.
Cat’s Eye also placed another new song, “ICONIC BY MISTAKE,” on the chart. This track, a collaboration with HYBE’s girl groups LE SSERAFIM and ILLIT, made its presence known by debuting at No. 85.
Meanwhile, “GOLDEN,” a track from the original soundtrack (OST) of the Netflix animated series “K-Pop Demon Hunters,” continued its long-running success by ranking at No. 49. It has now remained on the chart for an impressive 59 consecutive weeks.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

Shinwon Reports Improved Third-Quarter Earnings on the Back of Strong Exports

Fashion company Shinwon(009270)continues to show improved performance, driven by strong exports. This is attributed to the company’s expansion of its production and sales infrastructure, particularly …
2026-11-13 19:00:02

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02